JP2022502501A5 - - Google Patents

Info

Publication number
JP2022502501A5
JP2022502501A5 JP2021540398A JP2021540398A JP2022502501A5 JP 2022502501 A5 JP2022502501 A5 JP 2022502501A5 JP 2021540398 A JP2021540398 A JP 2021540398A JP 2021540398 A JP2021540398 A JP 2021540398A JP 2022502501 A5 JP2022502501 A5 JP 2022502501A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
formula
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021540398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/053032 external-priority patent/WO2020069043A1/en
Publication of JP2022502501A publication Critical patent/JP2022502501A/ja
Publication of JP2022502501A5 publication Critical patent/JP2022502501A5/ja
Priority to JP2024082290A priority Critical patent/JP2024109735A/ja
Pending legal-status Critical Current

Links

JP2021540398A 2018-09-25 2019-09-25 新規使用 Pending JP2022502501A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024082290A JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862736324P 2018-09-25 2018-09-25
US62/736,324 2018-09-25
PCT/US2019/053032 WO2020069043A1 (en) 2018-09-25 2019-09-25 Novel uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024082290A Division JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Publications (2)

Publication Number Publication Date
JP2022502501A JP2022502501A (ja) 2022-01-11
JP2022502501A5 true JP2022502501A5 (OSRAM) 2022-10-04

Family

ID=69953335

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021540398A Pending JP2022502501A (ja) 2018-09-25 2019-09-25 新規使用
JP2024082290A Pending JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024082290A Pending JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Country Status (4)

Country Link
US (1) US20210338679A1 (OSRAM)
EP (1) EP3856191A4 (OSRAM)
JP (2) JP2022502501A (OSRAM)
WO (1) WO2020069043A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020146384A1 (en) 2019-01-07 2020-07-16 Intra-Cellular Therapies, Inc. Organic compounds
CN114340636A (zh) 2019-09-03 2022-04-12 细胞内治疗公司 治疗方法
US20230071934A1 (en) * 2019-12-18 2023-03-09 Intra-Cellular Therapies, Inc. Novel uses
US12364695B2 (en) 2020-06-02 2025-07-22 Intra-Cellular Therapies, Inc. Methods of treating inflammatory disease
WO2025212780A1 (en) * 2024-04-02 2025-10-09 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006133261A2 (en) 2005-06-06 2006-12-14 Intra-Cellular Therapies, Inc. Organic compounds
JP5453086B2 (ja) 2006-06-06 2014-03-26 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物
CN104370920A (zh) 2007-12-06 2015-02-25 武田药品工业株式会社 有机化合物
WO2009073210A1 (en) 2007-12-06 2009-06-11 Intra-Cellular Therapies, Inc Organic compounds
BRPI0922700A2 (pt) 2008-12-06 2015-08-11 Intracellular Therapies Inc Compostos orgânicos
MX2011005935A (es) 2008-12-06 2011-12-16 Intra Cellular Therapies Inc Compuestos organicos.
JP5778582B2 (ja) 2008-12-06 2015-09-16 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
EA201170772A1 (ru) 2008-12-06 2012-03-30 Интра-Селлулар Терапиз, Инк. Органические соединения
EA201170771A1 (ru) 2008-12-06 2012-01-30 Интра-Селлулар Терапиз, Инк. Органические соединения
RU2591194C2 (ru) 2010-04-22 2016-07-10 Интра-Селлулар Терапиз, Инк. Органические соединения
US9434730B2 (en) 2010-05-31 2016-09-06 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9763948B2 (en) 2010-05-31 2017-09-19 Intra-Cellular Therapies, Inc. PDE1 inhibitory compounds and methods
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
US9308213B2 (en) * 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695431B2 (en) * 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
EP2846825B1 (en) * 2012-03-14 2021-05-05 The Regents of The University of California Treatment of inflammatory disorders in non-human mammals
US9598426B2 (en) 2013-03-15 2017-03-21 Intra-Cellular Therapies, Inc. Organic compounds
EP3970719A1 (en) * 2016-09-12 2022-03-23 Intra-Cellular Therapies, Inc. Pde1 inhibitor for use in a method of treatment or prophylaxis of inflammation and/or an inflammatory disease or disorder

Similar Documents

Publication Publication Date Title
JP2019531320A5 (OSRAM)
JP2024517942A5 (OSRAM)
JP2020045362A5 (OSRAM)
JP2021527125A5 (OSRAM)
JP2007533722A5 (OSRAM)
RU2002107203A (ru) Производные N-гетероциклических соединений в качестве ингибиторов синтазы оксида азота (nos)
JP2016534063A (ja) クロモリン誘導体ならびに関連するイメージングおよび治療方法
RU99108731A (ru) Применение аналогов сибутрамина для снижения уровней липидов
JP2018531289A5 (OSRAM)
JP2010522710A5 (OSRAM)
JPH039900B2 (OSRAM)
JP2008512426A5 (OSRAM)
JPH0920659A5 (OSRAM)
RU2005106356A (ru) Новое соединение
JP2006504738A5 (OSRAM)
RU2005106355A (ru) Новое соединение
JP2024507139A5 (OSRAM)
JP2022536160A5 (OSRAM)
JP2004532894A5 (OSRAM)
JP2022502501A (ja) 新規使用
JP2024521127A5 (OSRAM)
JP2010504321A5 (OSRAM)
JP2021520394A5 (OSRAM)
JP2023543924A5 (OSRAM)
WO2002083167A3 (en) Therapeutic compositions for the treatment of a respiratory tract disease